Increasing trends in mortality and costs of infectious diseases in Korea: trends in mortality and costs of infectious diseases
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
OBJECTIVES: In an era when the average life expectancy and overall mortality rate have improved, Korea remains at risk for infectious disease outbreaks that place substantial burdens on the healthcare system. This study investigated trends in mortality and the economic burden of infectious diseases. METHODS: Healthcare data from the Health Insurance Review and Assessment Service (2009-2019) and the Korean Statistics Information Service (1997-2019) were used. We selected 10 infectious disease groups (intestinal infections, tuberculosis, vaccinepreventable diseases, sepsis, viral hepatitis, HIV-related diseases, central nervous system infections, rheumatic heart diseases, respiratory tract infections, and arthropod-borne viral diseases). RESULTS: The age-standardized mortality rate for infectious diseases increased from 27.2 per 100,000 population in 1997 to 37.1 per 100,000 population in 2019 and has had an upward trend since 2004. During this same period, significant increases were seen in respiratory tract infections and among elderly persons, especially those aged ≥ 85 years. The costs for infectious diseases increased from 4.126 billion US dollar (USD) in 2009 to 6.612 billion USD in 2019, with respiratory tract infections accounting for 3.699 billion USD (69%). The annual cost per patient for visits for medical care due to infectious diseases increased from 131 USD in 2009 to 204 USD in 2019. CONCLUSIONS: Mortality among elderly persons and those with respiratory tract infections increased during the study period. The economic burden of infectious diseases has consistently increased, especially for respiratory tract infections. It is therefore essential to establish effective management policies that considers specific infectious diseases and patient groups.
Abstract
OBJECTIVES: In an era when the average life expectancy and overall mortality rate have improved, Korea remains at risk for infectious disease outbreaks that place substantial burdens on the healthcare system. This study investigated trends in mortality and the economic burden of infectious diseases. METHODS: Healthcare data from the Health Insurance Review and Assessment Service (2009-2019) and the Korean Statistics Information Service (1997-2019) were used. We selected 10 infectious disease groups (intestinal infections, tuberculosis, vaccinepreventable diseases, sepsis, viral hepatitis, HIV-related diseases, central nervous system infections, rheumatic heart diseases, respiratory tract infections, and arthropod-borne viral diseases). RESULTS: The age-standardized mortality rate for infectious diseases increased from 27.2 per 100,000 population in 1997 to 37.1 per 100,000 population in 2019 and has had an upward trend since 2004. During this same period, significant increases were seen in respiratory tract infections and among elderly persons, especially those aged ≥ 85 years. The costs for infectious diseases increased from 4.126 billion US dollar (USD) in 2009 to 6.612 billion USD in 2019, with respiratory tract infections accounting for 3.699 billion USD (69%). The annual cost per patient for visits for medical care due to infectious diseases increased from 131 USD in 2009 to 204 USD in 2019. CONCLUSIONS: Mortality among elderly persons and those with respiratory tract infections increased during the study period. The economic burden of infectious diseases has consistently increased, especially for respiratory tract infections. It is therefore essential to establish effective management policies that considers specific infectious diseases and patient groups.
참고문헌 (15)
- Choe YJ, "Trends in infectious disease mortality, South Korea, 1983-2015", Emerg Infect Dis, 24, pp.320~327 (2018)
- GBD 2015 Mortality and Causes of Death Collaborators, "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015", Lancet, 388, pp.1459~1544 (2016)
- "Death rate, crude (per 1,000 people) - Korea, Rep"[URL]
- "Life expectancy at birth, total (years)"[URL]
- Lee YR, "Disability-adjusted life years for communicable disease in the Korean burden of disease study 2012", J Korean Med Sci, 31(Suppl 2), pp.S178~S183 (2012)
- Jo C, "Cost-of-illness studies : concepts, scopes, and methods", Clin Mol Hepatol, 20, pp.327~337 (2014)
- Baik D, "Costs of viral hepatitis B in the Republic of Korea, 2002-2015", J Viral Hepat, 27, pp.156~167 (2020)
- 유광하, "Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis", Allergy, Asthma & Immunology Research, 8(6), pp.527~534 (2016), 대한천식알레르기학회
- Kim HS, "Age-period-cohort analysis of trends in infectious disease mortality in South Korea from 1983 to 2017", Int J Environ Res Public Health, 18, pp.906~ (2021)
- 김혜경, "Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database", Diabetes and Metabolism Journal, 44(5), pp.671~678 (2020), 대한당뇨병학회[DOI]
- Seong SC, "Data resource profile : the National Health Information Database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
- "Foreign exchange rate; 2021"[URL]
- "Consumer price index by item"[URL]
- "Global tuberculosis report 2019"[URL]
- National health insurance statistical yearbook 2020, "National Health Insurance Service", National Health Insurance Service, 1~200 (2020)